| Q44511579 | 03219A, a new Δ(8,9)-pregnene isolated from Streptomyces sp. SCSIO 03219 obtained from a South China Sea sediment |
| Q53841472 | 13-Deoxytetrodecamycin, a new tetronate ring-containing antibiotic that is active against multidrug-resistant Staphylococcus aureus. |
| Q47099739 | A Marine Actinomycete Rescues Caenorhabditis elegans from Pseudomonas aeruginosa Infection through Restitution of Lysozyme 7. |
| Q35781844 | A Pimarane Diterpene and Cytotoxic Angucyclines from a Marine-Derived Micromonospora sp. in Vietnam's East Sea |
| Q85317357 | A membrane-bound prenyltransferase catalyzes the O-prenylation of 1,6-dihydroxyphenazine in the marine bacterium Streptomyces sp. CNQ-509 |
| Q38619041 | A metabolomics guided exploration of marine natural product chemical space |
| Q34265851 | A new peptide isolated from a marine derived Streptomyces bacillaris |
| Q45234777 | A newly isolated Pseudomonas sp., epibiotic on the seaweed, Padina tetrastromatica, off Southeastern Coast of India, reveals antibacterial action |
| Q38814785 | Actinobacteria and Myxobacteria-Two of the Most Important Bacterial Resources for Novel Antibiotics |
| Q37153394 | Actinomycetes for marine drug discovery isolated from mangrove soils and plants in China |
| Q28658500 | Actinomycetes from Red Sea sponges: sources for chemical and phylogenetic diversity |
| Q39739619 | Actinoquinolines A and B, anti-inflammatory quinoline alkaloids from a marine-derived Streptomyces sp., strain CNP975. |
| Q33957218 | Actinoranone, a cytotoxic meroterpenoid of unprecedented structure from a marine adapted Streptomyces sp. |
| Q35588435 | Activation and enhancement of Fredericamycin A production in deepsea-derived Streptomyces somaliensis SCSIO ZH66 by using ribosome engineering and response surface methodology |
| Q28828652 | Activation of a plasmid-situated type III PKS gene cluster by deletion of a wbl gene in deepsea-derived Streptomyces somaliensis SCSIO ZH66 |
| Q29013706 | Activity of the streptogramin antibiotic etamycin against methicillin-resistant Staphylococcus aureus |
| Q90989744 | Akazamicin, a cytotoxic aromatic polyketide from marine-derived Nonomuraea sp |
| Q79888535 | Aligning pharmaceutical innovation with medical need |
| Q33648796 | Ammosamides A and B target myosin |
| Q33352116 | An N-acyl homolog of mycothiol is produced in marine actinomycetes |
| Q86490073 | An effective method based on wet-heat treatment for the selective isolation of Micromonospora from estuarine sediments |
| Q38121455 | Antagonistic interactions mediated by marine bacteria: the role of small molecules. |
| Q41512341 | Anthraquinones from a marine-derived Streptomyces spinoverrucosus |
| Q89975385 | Anti-Inflammatory Activity of Glycolipids and a Polyunsaturated Fatty Acid Methyl Ester Isolated from the Marine Dinoflagellate Karenia mikimotoi |
| Q36847122 | Anti-Inflammatory and Cytoprotective Effects of TMC-256C1 from Marine-Derived Fungus Aspergillus sp. SF-6354 via up-Regulation of Heme Oxygenase-1 in Murine Hippocampal and Microglial Cell Lines |
| Q38941917 | Anti-inflammatory effect of methylpenicinoline from a marine isolate of Penicillium sp. (SF-5995): inhibition of NF-κB and MAPK pathways in lipopolysaccharide-induced RAW264.7 macrophages and BV2 microglia. |
| Q39980978 | Anti-parasitic compounds from Streptomyces sp. strains isolated from Mediterranean sponges |
| Q30528009 | Antiamoebic properties of the actinomycete metabolites echinomycin A and tirandamycin A |
| Q57639488 | Antibacterial Activity of Marine Culturable Bacteria Collected from a Global Sampling of Ocean Surface Waters and Surface Swabs of Marine Organisms |
| Q47130095 | Antibacterial and Antioxidant Activities of Novel Actinobacteria Strain Isolated from Gulf of Khambhat, Gujarat |
| Q37040088 | Antibacterial and cytotoxic new napyradiomycins from the marine-derived Streptomyces sp. SCSIO 10428. |
| Q99635272 | Antimicrobial Chlorinated 3-Phenylpropanoic Acid Derivatives from the Red Sea Marine Actinomycete Streptomyces coelicolor LY001 |
| Q110171477 | Antimicrobial Metabolites from a Marine-Derived Actinomycete in Vietnam's East Sea |
| Q91633835 | Antimicrobial activity of bacteria from marine sponge Suberea mollis and bioactive metabolites of Vibrio sp. EA348 |
| Q35043670 | Antimicrobial activity of heterotrophic bacterial communities from the marine sponge Erylus discophorus (Astrophorida, Geodiidae) |
| Q46337276 | Antituberculotic activity of actinobacteria isolated from the rare habitats |
| Q37549963 | Antitumor compounds from marine actinomycetes |
| Q35942612 | Antiviral activities and putative identification of compounds in microbial extracts from the Hawaiian coastal waters |
| Q38992115 | Are There Any Other Compounds Isolated From Dermacoccus spp at All? |
| Q33721939 | Arenamides A-C, cytotoxic NFkappaB inhibitors from the marine actinomycete Salinispora arenicola |
| Q33673205 | Arenimycin, an antibiotic effective against rifampin- and methicillin-resistant Staphylococcus aureus from the marine actinomycete Salinispora arenicola |
| Q30837977 | Arthrobacter enclensis sp. nov., isolated from sediment sample |
| Q34891815 | Bacterial communities of the gorgonian octocoral Pseudopterogorgia elisabethae |
| Q33460654 | Bacterial production of the fungus-derived cholesterol-lowering agent mevinolin |
| Q40293724 | Binding and molecular dynamic studies of sesquiterpenes (2R-acetoxymethyl-1,3,3-trimethyl-4t-(3-methyl-2-buten-1-yl)-1t-cyclohexanol) derived from marine Streptomyces sp. VITJS8 as potential anticancer agent. |
| Q90774675 | Bioactive Diketopiperazines and Nucleoside Derivatives from a Sponge-Derived Streptomyces Species |
| Q33612242 | Bioactive Metabolites from the Deep Subseafloor Fungus Oidiodendron griseum UBOCC-A-114129. |
| Q42412549 | Bioactive compounds from marine actinomycetes |
| Q34451799 | Bioactive natural products from Papua New Guinea marine sponges. |
| Q41661871 | Biodiversity of Actinobacteria from the South Pacific and the Assessment of Streptomyces Chemical Diversity with Metabolic Profiling |
| Q50055322 | Bioprospecting of Novel and Bioactive Compounds from Marine Actinomycetes Isolated from South China Sea Sediments |
| Q78231500 | Bioprospection of Cytotoxic Compounds in Fungal Strains Recovered from Sediments of the Brazilian Coast |
| Q53688731 | Biosynthetic Potential of Bioactive Streptomycetes Isolated From Arid Region of the Thar Desert, Rajasthan (India). |
| Q33833371 | Borrelidins C-E: New Antibacterial Macrolides from a Saltern-Derived Halophilic Nocardiopsis sp |
| Q34470094 | CRISPR-Cas systems in the marine actinomycete Salinispora: linkages with phage defense, microdiversity and biogeography. |
| Q33406492 | Caboxamycin, a new antibiotic of the benzoxazole family produced by the deep-sea strain Streptomyces sp. NTK 937. |
| Q34361292 | Capturing the Essence of Organic Synthesis: From Bioactive Natural Products to Designed Molecules in Today’s Medicine |
| Q39973309 | Carpatamides A-C, cytotoxic arylamine derivatives from a marine-derived Streptomyces sp. |
| Q37625408 | Challenges and triumphs to genomics-based natural product discovery |
| Q39336383 | Characterization and phylogenetic analysis of novel polyene type antimicrobial metabolite producing actinomycetes from marine sediments: Bay of Bengal, India. |
| Q47948925 | Characterization of a potential β-lactamase inhibitory metabolite from a marine Streptomyces sp. PM49 active against multidrug-resistant pathogens |
| Q37226088 | Chasing the treasures of the sea - bacterial marine natural products. |
| Q64118870 | Chemical Profiling and Biological Screening of Some River Nile Derived-Microorganisms |
| Q21135556 | Chemical analyses of wasp-associated streptomyces bacteria reveal a prolific potential for natural products discovery |
| Q60332563 | Chemoecological studies on marine natural products: terpene chemistry from marine mollusks |
| Q36984688 | Chlorizidine, a cytotoxic 5H-pyrrolo[2,1-a]isoindol-5-one-containing alkaloid from a marine Streptomyces sp. |
| Q38086338 | Clinical relevance of the ESKAPE pathogens |
| Q35149474 | Clustered patterns of species origins of nature-derived drugs and clues for future bioprospecting |
| Q39840013 | Combinatorial strategies by marine cyanobacteria: symplostatin 4, an antimitotic natural dolastatin 10/15 hybrid that synergizes with the coproduced HDAC inhibitor largazole |
| Q92906413 | Comparative Genomic Insights into Secondary Metabolism Biosynthetic Gene Cluster Distributions of Marine Streptomyces |
| Q114868974 | Comparative Metabologenomics Analysis of Polar Actinomycetes |
| Q36534936 | Competitive strategies differentiate closely related species of marine actinobacteria. |
| Q37432493 | Crystal structures of ethyl {2-[4-(4-iso-propyl-phen-yl)thia-zol-2-yl]phen-yl}carbamate and ethyl {2-[4-(3-nitro-phen-yl)thia-zol-2-yl]phen-yl}carbamate. |
| Q35748515 | Culturable diversity and antimicrobial activity of Actinobacteria from marine sediments in Valparaíso bay, Chile |
| Q34993999 | Culturable rare Actinomycetes: diversity, isolation and marine natural product discovery. |
| Q59226292 | Cyanobacterial mats from hot springs produce antimicrobial compounds and quorum-sensing inhibitors under natural conditions |
| Q30950221 | Cycloexpansamines A and B: spiroindolinone alkaloids from a marine isolate of Penicillium sp. (SF-5292). |
| Q39308535 | Deep Sea Actinomycetes and Their Secondary Metabolites |
| Q37735703 | Development of novel drugs from marine surface associated microorganisms |
| Q50779410 | Developmental cycle and pharmaceutically relevant compounds of Salinispora actinobacteria isolated from Great Barrier Reef marine sponges. |
| Q35848525 | Diaza-anthracene Antibiotics from a Freshwater-Derived Actinomycete with Selective Antibacterial Activity toward Mycobacterium tuberculosis |
| Q38198771 | Discovering new bioactive molecules from microbial sources. |
| Q28540785 | Discovering the recondite secondary metabolome spectrum of Salinispora species: a study of inter-species diversity |
| Q35924624 | Discovery of cahuitamycins as biofilm inhibitors derived from a convergent biosynthetic pathway |
| Q35051542 | Diversity and antibacterial activity of bacteria cultured from Mediterranean Axinella spp. sponges |
| Q53685406 | Diversity and antimicrobial potential in sea anemone and holothurian microbiomes. |
| Q34077242 | Diversity and distribution of the bioactive actinobacterial genus Salinispora from sponges along the Great Barrier Reef |
| Q37674497 | Diversity and evolution of secondary metabolism in the marine actinomycete genus Salinispora |
| Q38035411 | Diversity and isolation of rare actinomycetes: an overview |
| Q35092495 | Diversity and novelty of actinobacteria in Arctic marine sediments |
| Q35867293 | Diversity of ABBA Prenyltransferases in Marine Streptomyces sp. CNQ-509: Promiscuous Enzymes for the Biosynthesis of Mixed Terpenoid Compounds |
| Q51147620 | Diversity of Gene Clusters for Polyketide and Nonribosomal Peptide Biosynthesis Revealed by Metagenomic Analysis of the Yellow Sea Sediment. |
| Q33375963 | Diversity of antibiotic-active bacteria associated with the brown alga Laminaria saccharina from the Baltic Sea. |
| Q38185243 | Diversity, abundance and natural products of marine sponge-associated actinomycetes. |
| Q82496476 | Do we need new antibiotics? The search for new targets and new compounds |
| Q89834974 | Donghaecyclinones A-C: New Cytotoxic Rearranged Angucyclinones from a Volcanic Island-Derived Marine Streptomyces sp |
| Q28829281 | Draft Genome Sequence of Arthrobacter enclensis NCIM 5488T for Secondary Metabolism |
| Q35057257 | Draft Genome Sequence of Marine Bacterium Streptomyces sp. Strain CNQ431, a Producer of the Cytokine Inhibitor Splenocin |
| Q33949077 | Draft Genome Sequence of Marine-Derived Actinomycete Nocardiopsis sp. Strain TP-A0876, a Producer of Polyketide Pyrones |
| Q35104247 | Draft Genome Sequence of Marine-Derived Streptomyces sp. TP-A0873, a Producer of a Pyrrolizidine Alkaloid Bohemamine |
| Q92795469 | Draft Genome Sequences of Three Sponge-Associated Actinomycetes Exhibiting Antimycobacterial Activity |
| Q36067296 | Draft genome sequence of marine-derived Streptomyces sp. TP-A0598, a producer of anti-MRSA antibiotic lydicamycins |
| Q34183390 | Draft genome sequence of the marine bacterium Streptomyces griseoaurantiacus M045, which produces novel manumycin-type antibiotics with a pABA core component |
| Q36807743 | Drug discovery from marine microbes |
| Q46217406 | Ecological implications of hypoxia-triggered shifts in secondary metabolism |
| Q41761257 | Engineering Streptomyces coelicolor for heterologous expression of secondary metabolite gene clusters. |
| Q38806940 | Engineering microbial hosts for production of bacterial natural products |
| Q34235119 | Erythrazoles A-B, cytotoxic benzothiazoles from a marine-derived Erythrobacter sp |
| Q46276489 | Evaluation of fermentation conditions triggering increased antibacterial activity from a near-shore marine intertidal environment-associated Streptomyces species |
| Q35844940 | Exploring omega-3 fatty acids, enzymes and biodiesel producing thraustochytrids from Australian and Indian marine biodiversity |
| Q28829854 | Exploring the Diversity and Antimicrobial Potential of Marine Actinobacteria from the Comau Fjord in Northern Patagonia, Chile |
| Q42239049 | Extraction and Identification of Antibacterial Secondary Metabolites from Marine Streptomyces sp. VITBRK2. |
| Q92240658 | Extreme Environment Streptomyces: Potential Sources for New Antibacterial and Anticancer Drug Leads? |
| Q35488704 | Fijimycins A-C, three antibacterial etamycin-class depsipeptides from a marine-derived Streptomyces sp. |
| Q33982435 | Fijiolides A and B, inhibitors of TNF-alpha-induced NFkappaB activation, from a marine-derived sediment bacterium of the genus Nocardiopsis |
| Q52664447 | Fluostatins M-Q Featuring a 6-5-6-6 Ring Skeleton and High Oxidized A-Rings from Marine Streptomyces sp. PKU-MA00045. |
| Q36994274 | Four new chloro-eremophilane sesquiterpenes from an Antarctic deep-sea derived fungus, Penicillium sp. PR19N-1 |
| Q34267241 | Genetic complementation of the obligate marine actinobacterium Salinispora tropica with the large mechanosensitive channel gene mscL rescues cells from osmotic downshock |
| Q35077331 | Genetic screening strategy for rapid access to polyether ionophore producers and products in actinomycetes |
| Q64273389 | Genome and metabolome mining of marine obligate Salinisporsatrains to discover new natural products |
| Q58700584 | Genome guided investigation of antibiotics producing actinomycetales strain isolated from a Macau mangrove ecosystem |
| Q24669895 | Genome sequencing reveals complex secondary metabolome in the marine actinomycete Salinispora tropica |
| Q46655875 | Genome-scale reconstruction of Salinispora tropica CNB-440 metabolism to study strain-specific adaptation. |
| Q34711979 | Genomic basis for natural product biosynthetic diversity in the actinomycetes |
| Q37358035 | Genomic islands link secondary metabolism to functional adaptation in marine Actinobacteria |
| Q39607777 | Genus-specific primers targeting the 16S rRNA gene for PCR detection of members of the genus Verrucosispora |
| Q82861874 | Gram-positive marine bacteria as a potential resource for the discovery of quorum sensing inhibitors |
| Q102048757 | Heterologous Expression of Cryptomaldamide in a Cyanobacterial Host |
| Q34074536 | Historical variation of structural novelty in a natural product library. |
| Q36018040 | Hormaomycins B and C: New Antibiotic Cyclic Depsipeptides from a Marine Mudflat-Derived Streptomyces sp. |
| Q37800557 | Hybrid isoprenoid secondary metabolite production in terrestrial and marine actinomycetes |
| Q43020791 | Identification and biosynthesis of new acyloins from the thermophilic bacterium Thermosporothrix hazakensis SK20-1(T). |
| Q28483917 | Identification of Sare0718 as an alanine-activating adenylation domain in marine actinomycete Salinispora arenicola CNS-205 |
| Q33736729 | In situ detection of antibiotic amphotericin B produced in Streptomyces nodosus using Raman microspectroscopy. |
| Q85272432 | Inhibition of Monoamine Oxidase by Anithiactins from Streptomyces sp |
| Q37840565 | Inhibitory activities of the marine streptomycete-derived compound SF2446A2 against Chlamydia trachomatis and Schistosoma mansoni. |
| Q35024717 | Integrated metagenomic and metatranscriptomic analyses of microbial communities in the meso- and bathypelagic realm of north pacific ocean |
| Q41565293 | Intertidal marine sediment harbours Actinobacteria with promising bioactive and biosynthetic potential |
| Q40399261 | Isolation and characterization of potential antibiotic producing actinomycetes from water and sediments of Lake Tana, Ethiopia |
| Q89415077 | Isolation and identification of two new compounds from marine-derived fungus Acremonium fusidioides RZ01 |
| Q46985436 | Isolation and partial characterization of bacteria (Pseudoalteromonas sp.) with potential antibacterial activity from a marine costal environment from New Caledonia |
| Q38697247 | Isolation and structure determination of a new diketopiperazine dimer from marine-derived fungus Aspergillus sp. SF-5280. |
| Q39508946 | Isolation of a small molecule with anti-MRSA activity from a mangrove symbiont Streptomyces sp. PVRK-1 and its biomedical studies in Zebrafish embryos |
| Q33561749 | Isolation, phylogenetic analysis and anti-infective activity screening of marine sponge-associated actinomycetes. |
| Q43438977 | JBIR-107, a new metabolite from the marine-sponge-derived actinomycete, Streptomyces tateyamensis NBRC 105047. |
| Q39772507 | JBIR-31, a new teleocidin analog, produced by salt-requiring Streptomyces sp. NBRC 105896 isolated from a marine sponge. |
| Q43118112 | JBIR-58, a new salicylamide derivative, isolated from a marine sponge-derived Streptomyces sp. SpD081030ME-02. |
| Q39692485 | JBIR-65, a new diterpene, isolated from a sponge-derived Actinomadura sp. SpB081030SC-15. |
| Q42821420 | JBIR-66, a New Metabolite Isolated from Tunicate-DerivedSaccharopolysporasp. SS081219JE-28 |
| Q42190344 | LC-MS-based metabolomics study of marine bacterial secondary metabolite and antibiotic production in Salinispora arenicola |
| Q26863108 | Lessons from the past and charting the future of marine natural products drug discovery and chemical biology |
| Q33646093 | Linking species concepts to natural product discovery in the post-genomic era |
| Q35826517 | Littoral lichens as a novel source of potentially bioactive Actinobacteria. |
| Q33645625 | Lodopyridone, a structurally unprecedented alkaloid from a marine actinomycete |
| Q35228218 | Lumazine peptides from the marine-derived fungus Aspergillus terreus |
| Q34508132 | Marine Actinobacteria from the Gulf of California: diversity, abundance and secondary metabolite biosynthetic potential |
| Q33799744 | Marine Rare Actinobacteria: Isolation, Characterization, and Strategies for Harnessing Bioactive Compounds. |
| Q91611900 | Marine Rare Actinomycetes: A Promising Source of Structurally Diverse and Unique Novel Natural Products |
| Q64887003 | Marine Spirotetronates: Biosynthetic Edifices That Inspire Drug Discovery. |
| Q35213551 | Marine actinobacteria associated with marine organisms and their potentials in producing pharmaceutical natural products |
| Q38088444 | Marine actinobacterial metabolites: current status and future perspectives. |
| Q37742166 | Marine natural product drug discovery: Leads for treatment of inflammation, cancer, infections, and neurological disorders |
| Q34007283 | Marine natural products: a new wave of drugs? |
| Q37327189 | Marine pharmacology in 2005-6: Marine compounds with anthelmintic, antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous |
| Q28534324 | Marine sediment-derived Streptomyces bacteria from British Columbia, Canada are a promising microbiota resource for the discovery of antimicrobial natural products |
| Q37126014 | Marineosins A and B, cytotoxic spiroaminals from a marine-derived actinomycete |
| Q41382473 | Marinocyanins, cytotoxic bromo-phenazinone meroterpenoids from a marine bacterium from the streptomycete clade MAR4. |
| Q38579139 | Marinopyrroles: Unique Drug Discoveries Based on Marine Natural Products |
| Q37017342 | Marizomib, a proteasome inhibitor for all seasons: preclinical profile and a framework for clinical trials |
| Q30853422 | Mass spectrometry tools and workflows for revealing microbial chemistry |
| Q34377262 | Metabolite profile of marine-derived endophytic Streptomyces sundarbansensis WR1L1S8 by liquid chromatography-mass spectrometry and evaluation of culture conditions on antibacterial activity and mycelial growth. |
| Q37400629 | Metabolites from symbiotic bacteria |
| Q57064132 | Metabolomic Investigations on Revealed Significant Differences between Marine and Terrestrial Actinomycetes |
| Q60958302 | Microbial Synthesis and Transformation of Inorganic and Organic Chlorine Compounds |
| Q35960244 | Microbial strain prioritization using metabolomics tools for the discovery of natural products. |
| Q35535108 | Miniaturized Cultivation of Microbiota for Antimalarial Drug Discovery |
| Q57149935 | Mining Actinomycetes for Novel Antibiotics in the Omics Era: Are We Ready to Exploit This New Paradigm? |
| Q29353836 | Modern natural products drug discovery and its relevance to biodiversity conservation |
| Q37263630 | Multilocus sequence typing reveals evidence of homologous recombination linked to antibiotic resistance in the genus Salinispora |
| Q43640390 | NMR spectroscopic and MS/MS spectrometric characterization of a new lipopeptide antibiotic bacillopeptin B1 produced by a marine sediment-derived Bacillus amyloliquefaciens SH-B74. |
| Q37486995 | Napyradiomycins CNQ525.510B and A80915C target the Hsp90 paralogue Grp94. |
| Q40052902 | Natural products and morphogenic activity of γ-Proteobacteria associated with the marine hydroid polyp Hydractinia echinata |
| Q37815398 | Naturally-occurring nitro compounds |
| Q38709618 | Neoantimycins A and B, Two Unusual Benzamido Nine-Membered Dilactones from Marine-Derived Streptomyces antibioticus H12-15. |
| Q57086661 | New Ansamycins from the Deep-Sea-Derived Bacterium sp. OUCMDZ-2164 |
| Q36847354 | New Cyclic Lipopeptides of the Iturin Class Produced by Saltern-Derived Bacillus sp. KCB14S006. |
| Q78436043 | New Diketopiperazine Derivatives Isolated from Sea Urchin-Derived Bacillus sp. |
| Q38065050 | New antimicrobial compounds from a marine-derived Bacillus sp. |
| Q61877471 | New bioactive compounds from the marine-derived actinomycete Nocardiopsis lucentensis sp. ASMR2 |
| Q35207034 | New methods to explore marine resources for Alzheimer's therapeutics. |
| Q43228615 | New potent DPPH radical scavengers from a marine-derived actinomycete strain USF-TC31. |
| Q34796592 | Nitropyrrolins A-E, cytotoxic farnesyl-α-nitropyrroles from a marine-derived bacterium within the actinomycete family Streptomycetaceae |
| Q46848688 | Novel 1,5,7-trihydroxy-3-hydroxy methyl anthraquinone isolated from terrestrial Streptomyces sp. (eri-26) with antimicrobial and molecular docking studies |
| Q37324603 | Novel approaches to discovery of antibacterial agents |
| Q92236792 | Omics Technologies to Understand Activation of a Biosynthetic Gene Cluster in Micromonospora sp. WMMB235: Deciphering Keyicin Biosynthesis |
| Q39034508 | Oxoprothracarcin, a novel pyrrolo[1,4]benzodiazepine antibiotic from marine Streptomyces sp. M10946. |
| Q44754424 | Palladium-catalyzed asymmetric hydrogenation of α-acyloxy-1-arylethanones |
| Q37369826 | Penicillinolide A: a new anti-inflammatory metabolite from the marine fungus Penicillium sp. SF-5292 |
| Q110169969 | Penidioxolanes A and B, 1,3-Dioxolane Containing Azaphilone Derivatives from Marine-derivedPenicilliumsp. KCB12C078 |
| Q37188300 | Penilumamide, a novel lumazine peptide isolated from the marine-derived fungus, Penicillium sp. CNL-338 |
| Q35952375 | Peptidolipins B-F, antibacterial lipopeptides from an ascidian-derived Nocardia sp. |
| Q35065758 | Pharmacological properties of the marine natural product marinopyrrole A against methicillin-resistant Staphylococcus aureus |
| Q37733391 | Photoprotective compounds from marine organisms |
| Q37264031 | Phylogenetic and chemical diversity of a hybrid-isoprenoid-producing streptomycete lineage |
| Q35129185 | Phylogenetic diversity and biological activity of actinobacteria isolated from the Chukchi Shelf marine sediments in the Arctic Ocean |
| Q84597119 | Phylogenetic diversity of acidophilic actinomycetes from Malaysia |
| Q26822731 | Phylogenetic framework and molecular signatures for the main clades of the phylum Actinobacteria |
| Q91671210 | Phytochemical analysis of Holothuria leucospilota, a sea cucumber from Persian Gulf |
| Q47997028 | Potent Inhibition of Monoamine Oxidase B by a Piloquinone from Marine-Derived Streptomyces sp. CNQ-027. |
| Q33422524 | Potent inhibitors of pro-inflammatory cytokine production produced by a marine-derived bacterium |
| Q28483792 | Pretubulysin: from hypothetical biosynthetic intermediate to potential lead in tumor therapy |
| Q34121673 | Production of a new thiopeptide antibiotic, TP-1161, by a marine Nocardiopsis species. |
| Q38202977 | Proteasome inhibitors - molecular basis and current perspectives in multiple myeloma |
| Q78438390 | Protulactones A and B: Two New Polyketides from the Marine-derived Fungus Aspergillus sp. SF-5044 |
| Q33708183 | Q&A: Antibiotic resistance: where does it come from and what can we do about it? |
| Q37678302 | QM-HiFSA-Aided Structure Determination of Succinilenes A-D, New Triene Polyols from a Marine-Derived Streptomyces sp. |
| Q41193471 | QSAR-assisted virtual screening of lead-like molecules from marine and microbial natural sources for antitumor and antibiotic drug discovery. |
| Q46938402 | Quorum sensing antagonism from marine organisms |
| Q33301941 | Rare actinomycete bacteria from the shallow water sediments of the Trondheim fjord, Norway: isolation, diversity and biological activity |
| Q37880884 | Rare actinomycetes: a potential storehouse for novel antibiotics |
| Q35657428 | Recent advances and applications of experimental technologies in marine natural product research. |
| Q36994135 | Recent advances in the discovery and development of marine microbial natural products. |
| Q96136096 | Role of symbiosis in the discovery of novel antibiotics |
| Q41772680 | Salinamide F, new depsipeptide antibiotic and inhibitor of bacterial RNA polymerase from a marine-derived Streptomyces sp. |
| Q33645464 | Salinipyrones and pacificanones, mixed-precursor polyketides from the marine actinomycete Salinispora pacifica |
| Q30586744 | Salinispora pacifica sp. nov., an actinomycete from marine sediments |
| Q34142223 | Salinosporamide Natural Products: Potent 20 S Proteasome Inhibitors as Promising Cancer Chemotherapeutics |
| Q110169975 | Salternamide E from a Saltern-derived Marine ActinomyceteStreptomycessp. |
| Q61780889 | Screening Microorganisms for Bioactive Compounds |
| Q38768313 | Screening for Anti-Cancer Compounds in Marine Organisms in Oman |
| Q26860194 | Scrutinizing the scaffolds of marine biosynthetics from different source organisms: Gram-negative cultured bacterial products enter center stage |
| Q46663876 | Seawater requirement for the production of lipoxazolidinones by marine actinomycete strain NPS8920. |
| Q110171483 | Secondary Metabolites from an Actinomycete from Vietnam's East Sea |
| Q102053820 | Selection of sponge-associated bacteria with high potential for the production of antibacterial compounds |
| Q37155588 | Separacenes A-D, novel polyene polyols from the marine actinomycete, Streptomyces sp. |
| Q33768204 | Sequence-based analysis of secondary-metabolite biosynthesis in marine actinobacteria |
| Q40429748 | Sequencing rare marine actinomycete genomes reveals high density of unique natural product biosynthetic gene clusters. |
| Q41899611 | Sponge-derived Kocuria and Micrococcus spp. as sources of the new thiazolyl peptide antibiotic kocurin |
| Q45342316 | Stereoselective total syntheses of (-)-flueggine A and (+)-virosaine B. |
| Q38952662 | Stereoselective total synthesis and structural elucidation of (-)-indoxamycins A-F. |
| Q30908664 | Streptomyces alkaliphilus sp. nov., isolated from sediments of Lake Elmenteita in the Kenyan Rift Valley |
| Q45061228 | Streptomyces associated with a marine sponge Haliclona sp.; biosynthetic genes for secondary metabolites and products |
| Q31016480 | Streptomyces hyaluromycini sp. nov., isolated from a tunicate (Molgula manhattensis). |
| Q116783913 | Streptomyces spiramenti sp. nov., isolated from a deep-sea microbial mat |
| Q27654081 | Structural Analysis of an Open Active Site Conformation of Nonheme Iron Halogenase CytC3 |
| Q42230518 | Structure and biosynthesis of the marine streptomycete ansamycin ansalactam A and its distinctive branched chain polyketide extender unit |
| Q35184486 | Structures and biosynthesis of the pyridinopyrones, polyenepyrones from a marine-derived Streptomyces species. |
| Q33908931 | Structures, reactivities, and antibiotic properties of the marinopyrroles A-F |
| Q34769635 | Studies on terpenoids produced by actinomycetes. 5-dimethylallylindole-3-carboxylic Acid and A80915G-8"-acid produced by marine-derived Streptomyces sp. MS239. |
| Q39394577 | Studies on the secondary metabolites of a Pseudoalteromonas sp. isolated from sediments collected at the northeastern coast of Brazil |
| Q105125506 | Synthesis, Structure and Antimicrobial Activity of Novel Metabolites from a Marine Actinomycete in Vietnam's East Sea |
| Q37424819 | Synthetic efforts for stereo structure determination of cytotoxic marine natural product pericosines as metabolites of Periconia sp. from sea hare |
| Q35541959 | Targeted capture and heterologous expression of the Pseudoalteromonas alterochromide gene cluster in Escherichia coli represents a promising natural product exploratory platform |
| Q34109331 | Terpenoids produced by actinomycetes: isolation, structural elucidation and biosynthesis of new diterpenes, gifhornenolones A and B from Verrucosispora gifhornensis YM28-088. |
| Q87823007 | Terretonin G, a new sesterterpenoid antibiotic from marine-derived Aspergillus sp. OPMF00272 |
| Q36808494 | The Hybrid Pyrroloisoindolone-Dehydropyrrolizine Alkaloid (-)-Chlorizidine A Targets Proteins within the Glycolytic Pathway |
| Q33644403 | The ammosamides: structures of cell cycle modulators from a marine-derived Streptomyces species |
| Q35580082 | The antimicrobial activity of heterotrophic bacteria isolated from the marine sponge Erylus deficiens (Astrophorida, Geodiidae) |
| Q46334128 | The diversity and antibiotic properties of actinobacteria associated with endemic deepwater amphipods of Lake Baikal. |
| Q34465208 | The marine actinomycete genus Salinispora: a model organism for secondary metabolite discovery |
| Q33648791 | The marinopyrroles, antibiotics of an unprecedented structure class from a marine Streptomyces sp. |
| Q36851585 | The occurrence of bioactive micromonosporae in aquatic habitats of the Sunshine Coast in Australia |
| Q37831943 | The phenomenon of resveratrol: redefining the virtues of promiscuity |
| Q35305715 | The soil resistome: a critical review on antibiotic resistance origins, ecology and dissemination potential in telluric bacteria. |
| Q46187012 | The variable hydroxamic acid siderophore metabolome of the marine actinomycete Salinispora tropica CNB-440. |
| Q51705368 | Therapeutic treasures from the deep. |
| Q38920460 | Thiasporines A-C, thiazine and thiazole derivatives from a marine-derived Actinomycetospora chlora |
| Q39394537 | Total synthesis and stereochemical reassignment of (±)-indoxamycin B. |
| Q34100015 | Total synthesis of sporolide B and 9-epi-sporolide B. |
| Q37172692 | Total synthesis of sporolide B. |
| Q33687964 | Total synthesis of the ammosamides |
| Q42747319 | Total synthesis: A cascade of new antibiotics |
| Q42077605 | Two antimycin A analogues from marine-derived actinomycete Streptomyces lusitanus |
| Q57837771 | Two interconverting Fe(IV) intermediates in aliphatic chlorination by the halogenase CytC3 |
| Q83262442 | Two new botcinin derivatives encountered in the studies of secondary metabolites from the marine-derived fungus Botryotinia sp. SF-5275 |
| Q41569920 | Upregulation and Identification of Antibiotic Activity of a Marine-Derived Streptomyces sp. via Co-Cultures with Human Pathogens. |
| Q24684235 | What's new in enzymatic halogenations |
| Q57764036 | YOU MAKE IT, I BREAK IT |
| Q40998067 | α-Pyrone Derivatives from a Streptomyces Strain Resensitize Tamoxifen Resistance in Breast Cancer Cells |